In a new paper published in Molecular Biology of the Cell, the Allain lab (IBC) reported that the phase separation of the SARS-CoV-2 N protein strongly depends on the chosen buffer and pH.

The antiviral combination of nirmatrelvir and ritonavir (brand name Paxlovid) is an effective treatment for people with COVID ...

The second possibility is that Covid has now settled into a rut, which will see it become progressively milder until it ultimately becomes akin to the common cold. Chin-Hong says that this would make ...

Researchers have developed a powerful tool that can detect variants of SARS-CoV-2 with high transmission potential before ...

The study explores the potential of chitosan derivatives as novel inhibitors against the wild-type and emerging variants of ...

The SARS-CoV-2 spike (S) protein mediates its attachment and entry into host cells by binding to the angiotensin converting enzyme (ACE2) receptor. The expression of ACE2, which is present at high ...

It is a near sphere of protein (cross section ... Structural proteins--N, M and E--move inside the cell, where they help new virions form. A SARS-CoV-2 particle enters a person's nose or mouth ...

Generally, testing for prior infections involves looking for antibodies that bind to viral proteins, particularly those that target SARS-CoV-2’s nucleocapsid (N) protein (anti-N antibodies), as the ...

Chitosan, a naturally occurring polysaccharide derived from chitin, has demonstrated significant potential as an antiviral ...